MOUNJARO
Used for Type 2 Diabetes and Weight loss
Are you tired of high medication costs? Our service offers unbeatable savings on your MOUNJARO prescription medication. We provide a range of solutions to help you save up to 100% on your medication costs*. Whether you are insured, uninsured, underinsured, or simply looking to reduce your out-of-pocket expenses, we've got you covered.
Manufactured by Eli Lilly & Company
*You can pay as little as $0 per fill using Drug Coupons or Patient Assistance Programs. Subject to applicability & eligibility requirements.
This content is intended for US audiences only
Start Saving Today!
Lower the cost of your MOUNJARO prescription
Unavailable
Patient Assistance ProgramsUnavailable
MOUNJARO key facts
What is MOUNJARO?
MOUNJARO is the brand name for tirzepatide and is available as a subcutaneous injection.
What dosages is MOUNJARO available in?
MOUNJARO is available as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen or single-dose vial.
What is MOUNJARO used for?
MOUNJARO is a GIP and GLP-1 agonist and is used to treat type 2 diabetes, in addition to diet and exercise.
How does MOUNJARO work?
MOUNJARO is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by acting like GLP-1 and GIP, two hormones released by your gut after you eat to help you control blood sugar. These hormones tell your body to release more insulin, release less sugar, and slow down digestion. All of these actions help lower blood sugar levels. In people who have Type 2 diabetes, GLP-1 and GIP don’t work as well they should. So MOUNJARO helps by acting just like GLP-1 and GIP to help control blood sugar.
How do I take MOUNJARO?
MOUNJARO is typically started at 2.5 mg injected under the skin of the stomach, thigh, or upper arm once weekly. After 4 weeks, your provider will raise your dose to 5 mg injected once weekly. Depending on your response, your provider might continue to raise your dose every 4 weeks or so until you’re at a dose that works for you. The maximum recommended dose is 15 mg once weekly.
Is it safe for me to take MOUNJARO?
MOUNJARO is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if you have any of the following. Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2. Known serious hypersensitivity to tirzepatide or any of the excipients in MOUNJARO.
MOUNJARO Common Side Effects
Common side effects of MOUNJARO:
- Nausea
- Diarrhea
- Low appetite
- Vomiting
- Stomach upset
- Constipation
- Stomach pain
MOUNJARO Serious Side Effects
Serious side effects are rare with MOUNJARO. Contact your healthcare provider immediately if you experience any of the following.
- Serious allergic reaction: hives; trouble breathing; swelling of your lips, tongue, throat, or face
- Dangerously low blood sugar: feeling hungry, fast heartbeat, shakiness, anxiety, sweating, tingling, dizziness, weakness, drowsiness, confusion
- Kidney damage: nausea, vomiting, trouble urinating, muscle cramps, feeling confused, swelling in the ankles or feet, trouble breathing
Effects of other drugs, drug classes and over-the-counter products on MOUNJARO
The following medications may interact with MOUNJARO:
- MOUNJARO delays gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications
Who makes MOUNJARO?
Eli Lilly & Company
Is MOUNJARO safe in pregnancy?
It is not known if MOUNJARO can harm your unborn baby. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
The FDA's medical product safety reporting program for health professionals, patients and consumers.
Learn more about reporting side effectsDrug Savings Guide
A practical guide to saving money and receiving support with prescription costs
How can NowPatient help me to lower the cost of my MOUNJARO prescription?
After you create a FREE account with NowPatient, you will have access to 4 programs that can help lower the cost of your MOUNJARO prescription
Applicability to each program will be dependent on your insurance status.
How do the NowPatient MOUNJARO savings programs work?
After you have created your FREE account with NowPatient, you can access the various programs from your account dashboard. Each program has clear instructions on how to check your eligibility. You can see how the process works by clicking on the feature link below and seeing the ‘How it works’ steps.
Drug Coupon and Patient Assistance Programs require an eligibility quiz to be completed.
Are the NowPatient MOUNJARO savings programs suitable for everyone, regardless of insurance status?
No. Each program has its own eligibility and applicability requirements. The table below shows if a program is available to you, based on your insurance status.
| Rx Advantage Card* for MOUNJARO | Canadian Prescription Savings* for MOUNJARO | MOUNJARO Drug Coupon* | MOUNJARO Patient Assistance Program* | |
| Insured (federal, state or government) | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
| Insured (Commercial or Private) | Available | Available | Available If Offered by Pharmaceutical Company | Available If Offered by Pharmaceutical Company |
| Uninsured | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
| Insured but without pharmacy benefit or drug coverage | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
*This is not insurance.
Are the NowPatient drug savings programs suitable for brand and generic versions of MOUNJARO?
No. Each program has applicability requirements. Please see below
| Rx Advantage Card* for MOUNJARO | Canadian Prescription Savings* for MOUNJARO | MOUNJARO Drug Coupon* | MOUNJARO Patient Assistance Program* | |
| Brand | Yes | Yes | Yes, If Offered by Pharmaceutical Company | Yes, If Offered by Pharmaceutical Company |
| Generic | Yes | Yes | No | No |
*This is not insurance.
If you have Medicare Part D or Medicare Advantage and none of the MOUNJARO savings options are applicable or affordable for me, what can you do?
If you are insured with Medicare and the MOUNJARO drug savings options are not applicable to you and still remain unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
The government site is easy to use and after you have selected your state, it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.
People who qualify for both Medicare and Medicaid are called ‘dual eligibles’.
If you are denied Medicaid for MOUNJARO, and you are still unable to afford your copay or co-insurance element (for example if you are in the coverage gap or Donut Hole) then you may be eligible for a federal support program like Low Income Subsidy. To be eligible for Low Income Subsidy, you need to be a resident in one of the 50 States or the District of Columbia. You can check eligibility online at SSA Medicare D Extra Help. You can also call Social Security at 1-800-772-1213 (TTY 1-800-325-0778).
I am uninsured or underinsured and none of the MOUNJARO prescription saving options are applicable or affordable for me, what can I do?
If you are uninsured or underinsured (for example, MOUNJARO is not covered by your plan) and the drug savings options are not applicable or still unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.
If you are denied and all else fails, and if you have been prescribed MOUNJARO for an FDA-approved indication, you can call the pharmaceutical company to see if they have any other assistance programs.
I am commercially or privately insured and none of the MOUNJARO prescription saving options are applicable or affordable for me, what can I do?
If your medication is not covered by your plan, you can you can appeal your insurance company’s decision. Sometimes, a formal appeal can result in the drug being covered if it is deemed medically necessary.
If you cannot afford your copay, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
However, being privately insured might complicate your eligibility for Medicaid, as having private insurance may be considered in the financial eligibility assessment.
The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. If you qualify, state Medicaid may cover the full cost of your medication.
If I have federal, state or commercial insurance and none of the MOUNJARO prescription saving options are applicable or affordable for me, are there any other support organisations that can help me with my co-insurance or copay?
If you have already tried Medicaid and received a denial letter or if you are insured with Medicare and have been denied Low-Income Subsidy, then you can try one of the following organizational support programs:
1. Patient Access Network Foundation (PAN) assistance for MOUNJARO
If you are having trouble paying for your MOUNJARO medication due to unaffordable copays or deductibles, the Patient Access Network Foundation (PAN), may be able to assist you. To qualify for PAN assistance for MOUNJARO you will need to meet one or all of the following criteria:
- Your income is below 400% of the federal poverty level
- MOUNJARO is prescribed for an approved FDA indication
- You live in and receive treatment in the United States or U.S. territories, even if you do not have U.S. citizenship
- You have Medicare insurance coverage that covers MOUNJARO
- If MOUNJARO is listed on PAN’s list of covered medications
You can check the Patient Access Network Foundation Website for more information.
2. HealthWell Foundation Copay Program for MOUNJARO
If you are having trouble paying for your MOUNJARO medication due to unaffordable copays or deductibles, the HealthWell Foundation Copay Program may be able to assist you. To qualify for assistance for MOUNJARO you will need to meet the following criteria:
- You live in and are being treated in the United States
- You are insured and your plan covers MOUNJARO
- If MOUNJARO is listed on the HealthWell Foundation’s list of covered medications
You can check the HealthWell Foundation Website for more information.
3. Patient Advocate Foundation Co-Pay Relief Program for MOUNJARO
Patient Advocate Foundation’s Co-Pay Relief program exists to help reduce the financial distress you or your family may face when paying for your MOUNJARO treatment. If you qualify and can demonstrate the need, the foundation will provide you with direct payment covering co-pays, co-insurance, and deductibles. To qualify for assistance for MOUNJARO you will need to meet the following criteria:
- You must be currently insured and have coverage for MOUNJARO
- You must have a confirmed diagnosis and treatment plan
- You must reside and receive treatment in the United States
- Your Income must fall at or below 300% or 400% of the Federal Poverty Guideline (FPG) with consideration for the Cost of Living Index (COLI) and number in the household
- Applications can also be completed by contacting the program sponsor, toll-free at 866-512-3861.
You can check the Patient Advocate Foundation Website for more information.
US brand name of MOUNJARO and manufacturer
Mounjaro is the brand name of tirzepatide and is available in the US under the brand name Mounjaro. It is manufactured by Eli Lilly
Source: Eli Lilly
UK brand name of MOUNJARO and manufacturer
Mounjaro is the brand name of tirzepatide and is available in the UK under the brand name Mounjaro. It is manufactured by Eli Lilly.
Is MOUNJARO available in the UK on the NHS?
Mounjaro is available on the NHS in the UK. It can be prescribed by healthcare providers for eligible patients.
Prescription requirement for MOUNJARO
Mounjaro (tirzepatide) is available as Pen 0.5ml of 2.5mg/0.5ml, Pen 0.5ml of 5mg/0.5ml, Pen 0.5ml of 7.5mg/0.5ml, Pen 0.5ml of 10mg/0.5ml, Pen 0.5ml of 12.5mg/0.5ml and Pen 0.5ml of 15mg/0.5ml injection pen. It is a prescription medicine and requires a valid prescription.
FDA approval of MOUNJARO
Mounjaro has received FDA approval for:
- Treatment of adults with type 2 diabetes as an adjunct to diet and exercise
It is not known if MOUNJARO is safe and effective for use in children under 18 years of age.
It is not known if MOUNJARO can be used in people who have had pancreatitis.
When not to use MOUNJARO?
There are certain precautions where Mounjaro may not be suitable if:
- You are allergic to tirzepatide or ingredients found in Mounjaro pen
- You have problems with your pancreas or kidney
- You have a history of diabetic retinopathy
- You are pregnant or breastfeeding or plan to become pregnant or breastfeed
- You or you family have had medullary thyroid carcinoma – MTC
- You have Multiple Endocrine Neoplasia syndrome type 2 -MEN 2
- You have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food
- You are taking insulin or sulfonylureas
- You take birth control pills by mouth? These may not work as well while using Mounjaro. Your healthcare provider may recommend another type of birth control when you start Mounjaro or when you increase your dose
- You have type 1 diabetes
Active ingredient of MOUNJARO and mechanism of action
Mounjaro is the first and only approved treatment in a different class of medication for type 2 diabetes. The active ingredient in Mounjaro is tirzepatide. Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It is the first and only unimolecular dual GIP/GLP-1 receptor agonist.
Both GIP and GLP-1 increase the production of insulin in your body.
It has proven to result in significant reductions in A1c levels and body weight. Mounjaro works in several ways:
- It increases insulin production, but only when your blood sugar is rising—which makes the risk of low blood sugar minimal
- It decreases your liver’s production of sugar
- It slows down the speed at which your stomach empties food into your intestine. This helps manage your blood sugars after eating while also leaving you feeling full longer
Is MOUNJARO as effective as Ozempic?
Mounjaro is more effective than Ozempic (semaglutide) for blood sugar control and weight loss. For people taking Mounjaro, 82% reached an A1C under 7% on the 5-mg dose, 86% reached an A1C under 7% on the 10-mg dose, and 86% reached an A1C under 7% on the 15-mg dose. For people taking Ozempic 1-mg, 79% reached an A1C under 7%.
The American Diabetes Association (ADA) recommends that a reasonable goal for most adults with type 2 diabetes is an HbA1C less than 7%.
Does MOUNJARO reduce cardiovascular risks?
It is not yet proven, however there may be a follow-through assumption of the Novo Nordisk Phase III SELECT trial of Wegovy (semaglutide) which showed a statistically significant reduction in major adverse cardiovascular events (MACE) of 20%. Eli Lilly is sponsoring the CVOT in obese patients, SURMOUNT-MMO, which is expected to yield data in 2027.
Can MOUNJARO be used for weight loss?
Mounjaro is not currently FDA approved for weight loss or chronic weight management, despite data that shows that there is significant weight loss associated with using Mounjaro.
In June 2023 Eli Lilly presented data from the Phase III SURMOUNT-2 study at the American Diabetes Association meeting, which showed a mean weight loss of 13.4% among patients receiving the 10mg dose and 15.7% for the 15mg dose after 72 weeks in overweight and obese patients with type 2 diabetes.
In August 2023, Eli Lilly confirmed that it had applied to the US Food and Drug Administration for the approval of Mounjaro for chronic weight management.
Some physicians and doctors are currently prescribing Mounjaro for weight loss, off-licence.
‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
Can MOUNJARO Pen be shared?
No. You should not share your Mounjaro pen with others, even if the needle is changed. You may give other people a serious infection or get a serious infection from them through cross-contamination.
Is it safe to use compounded MOUNJARO?
The manufacturer has said that they do not sell Mounjaro or the active ingredient tirzepatide for compounding. Eli Lilly is the sole company that has FDA approval to market Mounjaro and it is supplied in a branded box that includes a proprietary pen along with FDA-approved prescribing information. Eli Lilly cannot validate safety or effectiveness of products claiming to contain tirzepatide. Therefore, compounded Mounjaro should be avoided. While doctors can prescribe these medications “off-label” for obesity, insurance companies may deny these claims.
Is there a shortage of MOUNJARO?
Mounjaro, in all strengths, is available to community pharmacies nationwide for treatment in patients with type 2 diabetes. There may be normal delays given the time required to order the product from their local distribution center, and geographical variabilities. However, there are concerns about supply effects, in anticipation of the manufacturer confirming it will be looking to licence the product for chronic weight management.
Forms of MOUNJARO
Mounjaro comes as a solution in a prefilled, single-dose injection pen with the following dosage strengths:
- 2.5mg/0.5mL
- 5mg/0.5mL
- 7.5mg/0.5mL
- 10mg/0.5mL
- 12.5mg/0.5mL
- 15mg/0.5mL
Storage requirements for MOUNJARO
Mounjaro is temperature sensitive and should be handled as follows:
- Store your Pen in the refrigerator between 2C to 8C
- You may store your Pen at room temperature below 30C for up to a total of 21 days
- Do not freeze your Pen. If the Pen has been frozen, throw the Pen away and use a new Pen
- Store your Pen in the original carton to protect your Pen from light
- The Pen has glass parts. Handle it carefully. If you drop the Pen on a hard surface, do not use it. Use a new Pen for your injection
- Keep your MOUNJARO Pen and all medicines out of the sight and reach of children
Dosage of MOUNJARO
Mounjaro is given as a weekly injection under the skin (subcutaneous). It should be administered at the same time each week, at any time of the day. The 2.5-mg dose is for treatment initiation and is not intended for glycemic (blood sugar) control.
Patients are initiated with the 2.5-mg dose once weekly.
After 4 weeks on the 2.5-mg dose, the physician may increase to the 5-mg dose once weekly. If additional glycemic control is needed, the physician can continue to increase the dose by 2.5-mg increments after at least 4 weeks on the current dose. The maximum dose is 15 mg once weekly.
Source: Eli Lilly
Even though doses change, the administration frequency will always be weekly. It is important to follow the dosage instructions provided by your healthcare provider.
How long does it take for MOUNJARO to start working?
Mounjaro starts working immediately. It achieves glycaemic control faster than other treatment. SURPASS-2 and SURPASS-3 studies have shown that those taking any dose of Mounjaro reached A1C targets about 4 weeks sooner than those using injected semaglutide (Ozempic) 1 mg. When compared to titrated insulin degludec (Tresiba), participants using Mounjaro achieved the A1C goals between 4 and 12 weeks sooner.
How do I use the MOUNJARO Pen?
Follow these 4 steps to use your Mounjaro pen:
Step 1: Choose your injection site. Your healthcare provider can help you choose the injection site that is best for you. You or another person can inject the medicine in your stomach, thighs, or the back of your upper arms. Another person should give you the injection in the back of your upper arm.
Step 2: Pull off the base cap.
Step 3: Place the base flat on your skin, then unlock.
Step 4: Press and hold the button for up to 10 seconds. Listen for the first click. It means the injection has started. The second click means that the injection is complete.
How long can I continue using MOUNJARO?
Mounjaro is designed to be a long-term maintenance treatment. Mounjaro is safe and effective when used as indicated for the treatment of adults with type 2 diabetes to lower blood sugar, along with diet and exercise.
What are the common side effects of MOUNJARO?
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Indigestion
- Stomach pain
What are the serious side effects of MOUNJARO?
- Sudden inflammation of your pancreas (pancreatitis)
- Severe diarrhea, nausea, or vomitin
- Low blood sugar (hyproglycemia)
- Serious allergic reactions
- Possible risk of thyroid cancer
Contact your healthcare provider if you experience any serious side effects.
What can I do if I experience nausea when using MOUNJARO?
- Consume bland, low-fat foods, like crackers, toast, rice
- Eat smaller meals–try splitting your 3 daily meals into 4 or more smaller ones
- Stop eating when you feel full
- Avoid laying down after eating
- Avoid fat or fatty foods
- Drink ice-cold drinks
What support resources are there for MOUNJARO?
You can contact the Mounjaro patient services support center at 1-833-807-MJRO (833-807-6576).
What prescription assistance is available for MOUNJARO?
Prescription drug prices can be confusing. Two people may pay different prices for the same drug, depending on their insurance situation. The list price of Mounjaro is $1,023.04 per fill, but the amount you pay will largely depend on your prescription drug insurance plan.
Commercially insured patients may be eligible for the Mounjaro Savings Card program.
If you are not eligible for the Mounjaro Savings Program, then you may have to pay close to the list price shown above, plus any additional pharmacy charges depending on where you purchase your medicine.
If you are interested in obtaining insurance, there are resources available to help you:
- To find out if you qualify for Medicaid and for information about copayments in your state, please visit: https://www.medicaid.gov/state-overviews/index.html
- To learn more about private individual policies via the Insurance Marketplace, please visit: https://mat.org/Health-Insurance-Resources
For the most accurate information, talk to your insurance provider who knows the details of your plan.
Interactions with other drugs
Ozempic may interact with certain medications, including:
- Insulin (Humalog, Tresiba, Lantus, Basaglar, Fiasp)
- Sulfonylureas (Amayrl, glyburide, glipizide)
- Meglitinides (repaglinide, nateglinide)
- Birth control pills (drospirenone/estetrol, ethinyl estradiol/norethindrone, ethinyl estradiol/norgestimate)
- Ibuprofen
- Simvastatin
- Atorvastatin (Lipitor)
Sources
- FDA – Mounjaro
- Drugs.com – Mounjaro
- Eli Lilly – Mounjaro
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111